Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer-related molecular mechanisms research, RNA modifications and cancer, Cancer Immunotherapy and Biomarkers, and Cancer Cells and Metastasis.
Immune biomarkers in circulating cells of NSCLC patients can effectively evaluate the efficacy of chemotherapy combined with anti-PD-1 therapy
FOXD1 promotes proliferation, migration, and epithelial-mesenchymal transformation in esophageal squamous cell carcinoma by targeting SNAI1
Comprehensive pan-cancer analysis reveals prognostic implications of TMEM92 in the tumor immune microenvironment
FBXO22 Mediates the NGF/TRKA Signaling Pathway in Bone Metastases in Prostate Cancer
FOXD1 promotes proliferation, migration and epithelial-mesenchymal transformation of esophageal squamous cell carcinoma by targeting SNAI1
Effects of Long Noncoding RNA TUG1 (Taurine Up-Regulated Gene 1) on Growth and Metastasis of the Non-Small Cell Lung Cancer and Its Mechanism
Immune checkpoint inhibitors for treatment of small-cell lung cancer: a systematic review and meta-analysis
Synergistic combination therapy of lung cancer: Cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin
Long non-coding RNA TUG1 enhances chemosensitivity in non-small cell lung cancer by impairing microRNA-221-dependent PTEN inhibition
Analysis of soluble urokinase plasminogen activator receptor in multiple myeloma for predicting prognosis
Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer
Bortezomib prevents oncogenesis and bone metastasis of prostate cancer by inhibiting WWP1, Smurf1 and Smurf2